CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets

0
10



As a part of CME America’s dedication to high quality, following the beforehand introduced recall (April 27, 2020) of the BodyGuard® Infusion Pump Methods, the corporate performed extra flow-rate accuracy testing. This testing revealed that some infusion units don’t meet the ±5% supply accuracy for the



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here